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Retinal changes in patients with the acquired immune deficiency syndrome (AIDS) have frequently been described recently. The changes include cotton wool spots, superficial and deep retinal haemorrhages, perivasculitis, and a type of retinitis presumed to be caused by cytomegalovirus. 1-3
In our experience five out of seven eyes have progressed unremittingly to complete blindness, and until recently no effective treatment had been found for this disease. The nucleoside 9-(1, 3 dihydroxy 2-propoxymethyl) guanine is being investigated as a possible treatment. Our cases confirm the findings of Palestine et a1 that this drug is effective in treating retinitis caused by cytomegalovirus but that recurrence is likely after a single course of the drug.
Case reports
Case I-A 54 year old homosexual man with AIDS and cytomegalovirus myelopathy complained of left sided temporal field loss. His reading vision was N5 in both eyes, and a patch of nasal retinitis was seen. Sixteen days later he had no perception of light in the left eye, and the entire retina was inflamed. The right eye remained normal. He was readmitted two weeks later after noticing visual field loss in the right eye. He received treatment with dihydroxypropoxymethyl guanine 350 mg twice daily for two weeks, and during this time vision in the right eye remained 6/9 and N6. One week after the course of treatment the retinitis became active, and within two weeks the vision was lost and he had no perception of light in either eye. He died three weeks later.
Case 2-A 31 year old homosexual man with AIDS related complex presented with bilateral follicular conjunctivitis. He had 6/9 vision in both eyes. Fundoscopy showed a large area of peripheral retinal necrosis with a surrounding fluffy white border of Tetinitis in the upper temporal retina of the left eye. A presumptive diagnosis of retinitis due to cytomegalovirus was made. Two weeks later he still had 6/9 vision in both eyes, but he had an increased peripheral field defect and increased retinitis. He was admitted to hospital and received a two week course of dihydroxypropoxymethyl guanine 350 mg twice daily. During this period the area of retinitis remained static, but three weeks after he was discharged from hospital the vision in the left eye had deteriorated to registering only hand movements and the area of retinitis in the left eye had extended to the posterior pole (figure). There were disc haemorrhages, and the macula was oedematous. At this time a small patch of retinitis was noticed in the right eye. He received a further two week course ofdihydroxypropoxymethyl guanine and then treatment with a maintenance dose five days a week. The retinitis in both eyes steadily improved (figure), and at the time ofwriting the visual acuity was 6/6 in the right eye and had improved in the left from registering only hand movements to 6/12.
Comment
Cytomegalovirus is a deoxyribonucleic acid (DNA) virus of the herpes group, which causes a distinctive "owl's eye" cytopathogenic effect. It has been shown to cause destructive retinitis in immunosuppressed patients, most frequently patients with renal allografts. The immune response to cytomegalovirus is directed against the immediate early phase viral protein products and is mediated by T cells and natural killer cells.5 The nucleoside dihydroxypropoxymethyl guanine acts by inhibiting DNA polymerase in a way similar to acyclovir.
In patients with renal allografts retinitis responds to a reduction in immunosuppressant drugs. In our patients we have seen a good biological effect of the drug dihydroxypropoxymethyl guanine on retinitis thought to be caused by cytomegalovirus. In both cases withdrawal of the drug led to a rapid recurrence of the disease. Dihydroxypropoxymethyl guanine seems to 
